Riverain RS-2000 D Early Lung Cancer Detection System
RapidScreen® is the only Computer Aided Detection (CAD) for early-stage lung cancer to receive FDA premarket approval
Clinical Usage:
A DICOM-formatted thoracic chest image is pushed through the RapidScreen® Digital where processing is done in the background
CAD markings are either “burned” in to generate a derived image or become an integrated part of the original DICOM image that supports the DICOM standard for displaying graphical overlays on the original image
All image data coming onto the network is first funneled into the PACS server
The image studies are also sent to the RapidScreen® Digital.
When CAD processing is complete, the RapidScreen® Digital sends detection results to the PACS server where they are associated with the original study and are immediately available for query/retrieval and viewing by a physician through a networked PACS workstation
RapidScreen® Digital can send detection results to a maximum of five destinations, allowing easy integration into a wide variety of clinical workflow configurations.
Clinical testing with analog CAD has proven that radiologists’ ability to detect lung cancer with CAD is improved by more than 20 percent for 9-15 mm cancers (relative detection rate from 58 to 70%)
9-15 mm cancers present the most significant opportunity for better detection and earlier treatment for patients
RapidScreen® RS-Digital CAD Processor
- a Value Proposition
Adds value to institution’s CR and DR investment and gives film digitizers new functionality Processes in the background so department workflow is not interrupted
Simplifies viewing by displaying CAD overlay on a compliant PACS workstation monitor
Offers proven ability to find early-stage lung cancers, which translates into follow-on medical procedures and treatments that insurers will reimburse
Ensures that diagnostic reading quality for detecting early-stage lung cancer is maintained at high levels throughout the day
